What is the share price of CCME Global Ltd (GENESIS) today?
The share price of GENESIS as on 15th April 2026 is ₹77.43. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on CCME Global Ltd (GENESIS) share?
The past returns of CCME Global Ltd (GENESIS) share are- Past 1 week: -11.56%
- Past 1 month: -26.92%
- Past 3 months: -5.23%
- Past 6 months: -30.30%
- Past 1 year: 302.23%
- Past 3 years: 624.32%
- Past 5 years: 937.94%
What are the peers or stocks similar to CCME Global Ltd (GENESIS)?
The peers or stocks similar to CCME Global Ltd (GENESIS) include:What is the market cap of CCME Global Ltd (GENESIS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of CCME Global Ltd (GENESIS) is ₹131.30 Cr as of 15th April 2026.What is the 52 week high and low of CCME Global Ltd (GENESIS) share?
The 52-week high of CCME Global Ltd (GENESIS) is ₹184.90 and the 52-week low is ₹19.25.What is the PE and PB ratio of CCME Global Ltd (GENESIS) stock?
The P/E (price-to-earnings) ratio of CCME Global Ltd (GENESIS) is 37.41. The P/B (price-to-book) ratio is 15.39.Which sector does CCME Global Ltd (GENESIS) belong to?
CCME Global Ltd (GENESIS) belongs to the Health Care sector & Biotechnology sub-sector.How to buy CCME Global Ltd (GENESIS) shares?
You can directly buy CCME Global Ltd (GENESIS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
CCME Global Ltd
GENESIS Share Price
BSE₹77.430.49% (+0.38)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
GENESIS Stock Scorecard
Performance
HighThe creamy layer - amongst the top performing stocks
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
GENESIS Performance & Key Metrics
GENESIS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -570.87 | 15.39 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 34.78 | 5.49 | 0.61% |
GENESIS Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
GENESIS Company Profile
Genesis IBRC India Ltd develops microbial and antimicrobial products for aquaculture, agriculture, and animal husbandry.
BIOCON
PE Ratio
58.67
58.67
1Y Return
6.54%
6.54%
Buy Reco %
80.00
80.00
ANTHEM
PE Ratio
78.23
78.23
1Y Return
0.08%
0.08%
Buy Reco %
100.00
100.00
SAILIFE
PE Ratio
123.01
123.01
1Y Return
27.27%
27.27%
Buy Reco %
100.00
100.00
ACUTAAS
PE Ratio
117.00
117.00
1Y Return
94.86%
94.86%
Buy Reco %
100.00
100.00
ONESOURCE
PE Ratio
-886.53
-886.53
1Y Return
1.88%
1.88%
Buy Reco %
100.00
100.00
GENESIS Forecast
GENESIS Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
GENESIS
GENESIS
Income
Balance Sheet
Cash Flow
Quarterly Normal View
GENESIS Income Statement
GENESIS Income Statement
Quarterly Normal View
| Quarter | sep 2023 | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 3.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
Operating & Other expenses | 0.02 | 0.02 | 3.69 | 0.10 | 0.02 | 0.03 | 0.02 | 0.12 | 0.06 | 0.03 | ||||||||||
EBITDA | -0.02 | -0.02 | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 | -0.12 | -0.06 | -0.03 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBIT | -0.02 | -0.02 | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 | -0.12 | -0.06 | -0.03 | ||||||||||
| Interest & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| PBT | -0.02 | -0.02 | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 | -0.12 | -0.06 | -0.03 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Net Income | -0.02 | -0.02 | -3.69 | -0.10 | 3.65 | -0.03 | -0.02 | -0.12 | -0.06 | -0.03 | ||||||||||
| EPS | -0.02 | -0.02 | -2.84 | -0.07 | 2.81 | -0.02 | -0.02 | -0.09 | -0.05 | -0.02 |
GENESIS Company Updates
GENESIS Stock Peers
GENESIS Past Performance & Peer Comparison
GENESIS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareBiotechnology
Compare valuation on Screener
Health CareBiotechnology
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| CCME Global Ltd | 37.41 | 15.39 | — |
| Biocon Ltd | 58.67 | 2.15 | 0.10% |
| Anthem Biosciences Ltd | 78.23 | 14.65 | — |
| Sai Life Sciences Ltd | 123.01 | 9.83 | — |
GENESIS Stock Price Comparison
Compare GENESIS with any stock or ETFCompare GENESIS with any stock or ETF
GENESIS
GENESIS Holdings
GENESIS Shareholdings
GENESIS Promoter Holdings Trend
GENESIS Promoter Holdings Trend
GENESIS Institutional Holdings Trend
GENESIS Institutional Holdings Trend
Decreased Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has decreased by 2.61%
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
GENESIS Shareholding Pattern
GENESIS Shareholding Pattern
GENESIS Shareholding History
GENESIS Shareholding History
Foreign Institutions
smallcases containing GENESIS stock
smallcases containing GENESIS stock
Looks like this stock is not in any smallcase yet.
GENESIS Events
GENESIS Events
GENESIS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
GENESIS has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
GENESIS Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
GENESIS has not given any dividends in last 5 years
GENESIS Dividends
GENESIS Dividends
Hmm, looks like data is unavailable here. Please come back after some timeGENESIS Stock News & Opinions
GENESIS Stock News & Opinions
Articles & Videos
Earnings
Genesis IBRC India reports standalone net loss of Rs 0.03 crore in the December 2025 quarter
Net Loss of Genesis IBRC India reported to Rs 0.03 crore in the quarter ended December 2025 as against net loss of Rs 0.03 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 and during the previous quarter ended December 2024.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Genesis IBRC India to announce Quarterly Result
Genesis IBRC India will hold a meeting of the Board of Directors of the Company on 14 February 2026.Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Genesis IBRC India to declare Quarterly Results
Genesis IBRC India will hold a meeting of the Board of Directors of the Company on 28 January 2026.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Genesis IBRC India reports standalone net loss of Rs 0.06 crore in the September 2025 quarter
Net loss of Genesis IBRC India reported to Rs 0.06 crore in the quarter ended September 2025 as against net profit of Rs 3.65 crore during the previous quarter ended September 2024. There were no Sales reported in the quarter ended September 2025 as against Rs 3.67 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales03.67 -100 OPM %099.46 - PBDT-0.063.65 PL PBT-0.063.65 PL NP-0.063.65 PL Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Genesis IBRC India to table results
Genesis IBRC India will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Genesis IBRC India to convene AGM
Genesis IBRC India announced that the 33th Annual General Meeting(AGM) of the company will be held on 30 September 2025.Powered by Capital Market - Live
7 months agoCapital Market - Live
Earnings
Genesis IBRC India reports standalone net loss of Rs 0.12 crore in the June 2025 quarter
Net Loss of Genesis IBRC India reported to Rs 0.12 crore in the quarter ended June 2025 as against net loss of Rs 0.10 crore during the previous quarter ended June 2024. There were no Sales reported in the quarter ended June 2025 and during the previous quarter ended June 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Genesis IBRC India to convene board meeting
Genesis IBRC India will hold a meeting of the Board of Directors of the Company on 14 August 2025.Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Genesis IBRC India reports standalone net loss of Rs 0.02 crore in the March 2025 quarter
Net Loss of Genesis IBRC India reported to Rs 0.02 crore in the quarter ended March 2025 as against net loss of Rs 3.69 crore during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024. For the full year,net profit reported to Rs 3.50 crore in the year ended March 2025 as against net loss of Rs 3.80 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Corporate
Genesis IBRC India to convene board meeting
Genesis IBRC India will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live
10 months agoCapital Market - Live
Pledged promoter holdings is insignificant